Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FZP81
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,415
Award facts
- Contract value 100% obligated
- $10,414.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,414.65 to DMS Pharmaceutical Group Inc. for the supply of Nexplanon 68 mg implants, with an ultimate completion date of June 25, 2025. This is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL 60068. The company has been registered in the System for Award Management (SAM) since 2001 and specializes in distributing pharmaceuticals and medical supplies to federal agencies, particularly military healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent IDC enables DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. Nexplanon implants are a contraceptive device included within the broader pharmaceutical portfolio covered by this strategic contract vehicle, positioning DMS Pharmaceutical Group as a critical supplier in the federal pharmaceutical supply chain for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FZP81?
SPE2DB25FZP81 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 3, 2025.
How much is contract SPE2DB25FZP81 worth?
The government has obligated $10,415 on SPE2DB25FZP81.
Is contract SPE2DB25FZP81 an order under another contract?
Yes. SPE2DB25FZP81 is a delivery order under SPE2DB22D9102, an indefinite delivery contract.
Was contract SPE2DB25FZP81 competed?
The extent of competition for SPE2DB25FZP81 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award